Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated Caenorhabditis elegans
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2216141120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Adriana Raluca Vintila und 13 weiteren Autor:innen. Beteiligte Einrichtung: Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter EX1 2LU, United Kingdom. Hauptthemen laut MEDLINE: Caenorhabditis elegans Proteins, Hydrogen Sulfide. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Biotechnology and Biological Sciences Research Council, DOD | USA | USACE | ERDC | International Research Office.
Abstract (Originalsprache)
Living longer without simultaneously extending years spent in good health (“health span”) is an increasing societal burden, demanding new therapeutic strategies. Hydrogen sulfide (H 2 S) can correct disease-related mitochondrial metabolic deficiencies, and supraphysiological H 2 S concentrations can pro health span. However, the efficacy and mechanisms of mitochondrion-targeted sulfide delivery molecules (mtH 2 S) administered across the adult life course are unknown. Using a Caenorhabditis elegans aging model, we compared untargeted H 2 S (NaGYY4137, 100 µM and 100 nM) and mtH 2 S (AP39, 100 nM) donor effects on life span, neuromuscular health span, and mitochondrial integrity. H 2 S donors were administered from birth or in young/middle-aged animals (day 0, 2, or 4 postadulthood). RNAi pharmacogenetic interventions and transcriptomics/network analysis explored molecular events governing mtH 2 S donor-mediated health span. Developmentally administered mtH 2 S (100 nM) improved life/health span vs. equivalent untargeted H 2 S doses. mtH 2 S preserved aging mitochondrial structure, content (citrate synthase activity) and neuromuscular strength. Knockdown of H 2 S metabolism enzymes and FoxO/ daf-16 prevented the positive health span effects of mtH 2 S, whereas DCAF11/ wdr-23 – Nrf2/ skn-1 oxidative stress protection pathways were dispensable. Health span, but not life span, increased with all adult-onset mtH 2 S treatments. Adult mtH 2 S treatment also rejuvenated aging transcriptomes by minimizing expression declines of mitochondria and cytoskeletal components, and peroxisome metabolism hub components, under mechanistic control by the elt-6 / elt-3 transcription factor circuit. H 2 S health span extension likely acts at the mitochondrial level, the mechanisms of which dissociate from life span across adult vs. developmental treatment timings. The small mtH 2 S doses required for health span extension, combined with efficacy in adult animals, suggest mtH 2 S is a potential healthy aging therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter EX1 2LU, United Kingdom.
- University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter EX1 2LU, United Kingdom.
- Medical Research Council Versus Arthritis Centre for Musculoskeletal Ageing Research, Nottingham Biomedical Research Center, School of Medicine, Royal Derby Hospital, University of Nottingham, Derby DE22 3DT, United Kin…
- School of Chemistry and Biosciences, Faculty of Life Sciences, University of Bradford, Bradford BD7 1DP, United Kingdom.
- Department of Chemical Engineering, Texas Tech University, Lubbock, TX 79409.
- Department of Electrical Engineering, Texas Tech University, Lubbock, TX 74909.
ORCID-Profile: Adriana Raluca Vintila, Luke Slade, Michael Cooke, Roberta Torregrossa, Siva A Vanapalli, Christopher J Gaffney, Csaba Szabo, Nathaniel J Szewczyk, Matthew Whiteman, Timothy Etheridge
Förderung
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- DOD | USA | USACE | ERDC | International Research Office
- United Mitochondrial Disease Foundation
- UK Space Agency
- UKRI | Biotechnology and Biological Sciences Research Council
- NASA Exoplanet Science Institute
Zitieren
APA
Vintila, A. R., Slade, L., Cooke, M., Willis, C. R. G., Torregrossa, R., Rahman, M., Anupom, T., Vanapalli, S. A., Gaffney, C. J., Gharahdaghi, N., Szabo, C., Szewczyk, N. J., Whiteman, M., & Etheridge, T. (2023). Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated Caenorhabditis elegans. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2216141120
Vancouver
Vintila AR, Slade L, Cooke M, Willis CRG, Torregrossa R, Rahman M, et al. Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated Caenorhabditis elegans. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2216141120
BibTeX
@article{Vintila2023,
author = {Vintila, Adriana Raluca and Slade, Luke and Cooke, Michael and Willis, Craig R G and Torregrossa, Roberta and Rahman, Mizanur and Anupom, Taslim and Vanapalli, Siva A and Gaffney, Christopher J and Gharahdaghi, Nima and Szabo, Csaba and Szewczyk, Nathaniel J and Whiteman, Matthew and Etheridge, Timothy},
title = {Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated Caenorhabditis elegans},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2216141120}
}
EUVIMED